Open AccessCase report of penile cancer recurrence treated with cetuximab combined with anlotinib
Author(s) -
Dai Shuang,
Liu YanYang,
Liu Tao,
Zhang Yu,
Luo DeYun
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5443
Subject(s) - cetuximab , medicine , penile cancer , oncology , lymph node , cancer , colorectal cancer
Penile squamous cell carcinoma with pelvic lymph node metastases/recurrence has a poor prognosis. We reported a case with recurrent pSCC was administered cetuximab and anlotinib after failure of first‐line treatment and achieved an effective response. Cetuximab combined with anlotinib may be a new choice for relapsed pSCC.